Peter Diamandis

Rank 9 of 47

|

Score 109

Peter H. Diamandis, MD

@PeterDiamandis

+3

The process today is expensive for sure... Once it is FDA approved, likely to be in the $20K - $30K depending on volume. Hopefully this and other longevity therapies will all "demonetize" with volume.

8/22/2025, 1:01:07 AM

In reply to:

Peter H. Diamandis, MD

@PeterDiamandis

·

153d

Peter H. Diamandis, MD

@PeterDiamandis

·

153d

Undergoing “StemCell reeducation” ⁦@ThroneBiotech⁩ - processed 10L of blood, extracting 300cc of white cells. Tonight those cells are co-incubated with cord blood stem cells to bring them to factory reset. I get them back tomorrow!!

The statement discusses the cost and potential future affordability of longevity therapies, touching on public health and economic issues.

Principle 1:
I will strive to do no harm with my words and actions.
The statement does not cause harm and provides information about potential costs and benefits. [+1]
Principle 3:
I will use my words and actions to promote understanding, empathy, and compassion.
It promotes understanding by discussing the economic aspects of medical therapies. [+1]
Principle 6:
I will use my influence for the betterment of society.
It uses the platform to discuss the potential societal benefits of making therapies more affordable. [+1]